Genetically engineered mouse models for hereditary cancer syndromes
Cancer Science · 2023
DOI: 10.1111/cas.15737 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Science, 2023. Verfasst von Kajal Biswas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland, USA. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Hereditary Nonpolyposis, Neoplastic Syndromes, Hereditary, Hereditary Breast and Ovarian Cancer Syndrome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Advances in molecular diagnostics have led to improved diagnosis and molecular understanding of hereditary cancers in the clinic. Improving the management, treatment, and potential prevention of cancers in carriers of predisposing mutations requires preclinical experimental models that reflect the key pathogenic features of the specific syndrome associated with the mutations. Numerous genetically engineered mouse (GEM) models of hereditary cancer have been developed. In this review, we describe the models of Lynch syndrome and hereditary breast and ovarian cancer syndrome, the two most common hereditary cancer predisposition syndromes. We focus on Lynch syndrome models as illustrative of the potential for using mouse models to devise improved approaches to prevention of cancer in a high‐risk population. GEM models are an invaluable tool for hereditary cancer models. Here, we review GEM models for some hereditary cancers and their potential use in cancer prevention studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland, USA.
- Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland, USA.
ORCID-Profile: Kajal Biswas
Zitieren
APA
Biswas, K., Mohammed, A., Sharan, S. K., & Shoemaker, R. H. (2023). Genetically engineered mouse models for hereditary cancer syndromes. Cancer Science. https://doi.org/10.1111/cas.15737
Vancouver
Biswas K, Mohammed A, Sharan SK, Shoemaker RH. Genetically engineered mouse models for hereditary cancer syndromes. Cancer Science. 2023. doi:10.1111/cas.15737
BibTeX
@article{Biswas2023,
author = {Biswas, Kajal and Mohammed, Altaf and Sharan, Shyam K and Shoemaker, Robert H},
title = {Genetically engineered mouse models for hereditary cancer syndromes},
journal = {Cancer Science},
year = {2023},
doi = {10.1111/cas.15737}
}
EUVIMED